Advertisement
Advertisement

ARAY

ARAY logo

Accuray Incorporated

0.38
USD
Sponsored
-0.04
-10.22%
Apr 07, 14:27 UTC -4
Closed
exchange

After-Market

0.38

+0.01
+1.33%

ARAY Earnings Reports

Positive Surprise Ratio

ARAY beat 24 of 40 last estimates.

60%

Next Report

Date of Next Report
Apr 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$114.14M
/
-$0.04
Implied change from Q2 26 (Revenue/ EPS)
+11.64%
/
-63.64%
Implied change from Q3 25 (Revenue/ EPS)
+0.79%
/
+300.00%

Accuray Incorporated earnings per share and revenue

On Feb 04, 2026, ARAY reported earnings of -0.11 USD per share (EPS) for Q2 26, beating the estimate of -0.11 USD, resulting in a 1.96% surprise. Revenue reached 102.24 million, compared to an expected 102.87 million, with a -0.61% difference. The market reacted with a -20.68% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 114.14 million USD, implying an decrease of -63.64% EPS, and increase of 11.64% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
logo
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
logo
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
logo
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
logo
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
logo
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
logo
Lucid Diagnostics Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
logo
Microbot Medical, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+34.64%
logo
EDAP TMS SA
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.22
Surprise
-69.10%
logo
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
FAQ
For Q2 2026, Accuray Incorporated reported EPS of -$0.11, beating estimates by 1.96%, and revenue of $102.24M, -0.61% below expectations.
The stock price moved down -20.68%, changed from $0.76 before the earnings release to $0.60 the day after.
The next earning report is scheduled for Apr 28, 2026.
Based on 4 analysts, Accuray Incorporated is expected to report EPS of -$0.04 and revenue of $114.14M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement